Market Overview

PathMaker Neurosystems Appoints Medical Device Industry Veteran Jean-Luc Boulnois to Board of Directors


Neurosystems Inc
. ("PathMaker"), a clinical-stage bioelectronic
medicine company developing non-invasive systems for the treatment of
patients with neuromotor disorders, has appointed Jean-Luc Boulnois,
E.M.B.A, Ph.D., to the Company's Board of Directors. Dr. Boulnois has
over 30 years of international leadership experience in creating,
operating, and financing medical device companies, with which he led
several mergers, acquisitions, and financing rounds.

"I am delighted to have Jean-Luc join our Board of Directors," said
Nader Yaghoubi, M.D., Ph.D., President and Chief Executive Officer of
PathMaker. "I believe Jean-Luc's strategic vision and leadership roles
in medical device companies will add tremendous value to PathMaker's
board. I look forward to leveraging his vast industry experience as we
advance our first-in-class neuromodulation products toward

"I am very pleased to be joining PathMaker's board," Dr. Boulnois
commented. "PathMaker is a dynamic and exciting company with a
transformative non-invasive neuromodulation technology that has the
potential to change how various chronic neuromotor disorders are

Dr. Boulnois is CEO of Quadrature, a strategic advisory firm for MedTech
companies. For 11 years Dr. Boulnois has been Chairman and CEO of
Microline Surgical, Inc., a worldwide leader in disposable
electro-surgical instruments. Previously he served as Venture Partner at
Dover Medical Ventures, a Boston-based venture fund; he also has been
Executive Director at Arrow International and co-developer and CEO of
Sometec, a cardiovascular monitoring company. He previously was
President and COO of Technomed International Inc., a urology company
listed on the Paris "Second Marché" through an IPO; he also has been
Vice-President of Research at Quantel SA where he developed several
scientific and medical lasers.

Dr. Boulnois served for 4 years on the Princeton University Mechanical
and Aerospace Engineering Department Advisory Council; he recently
served as Director of a public company listed on the Euronext and now
serves on the Board of several venture capital financed private medical
device firms in the US and Europe. Dr. Boulnois is co-author of 5 books
and more than 35 peer-reviewed scientific articles in applied physics
and biophysics; he is an Adjunct Professor at Babson College and
previously was a Lecturer at Princeton University. He holds an M.Sc.
from Paris University, an E.M.B.A. from HEC in Paris, and a Ph.D. in
Mechanical and Aerospace Engineering from Princeton University. Dr.
Boulnois is bi-national American and French and has lived for 33 years
in the United States.

About PathMaker Neurosystems Inc.
PathMaker Neurosystems is
a clinical-stage bioelectronic medicine company developing breakthrough
non-invasive systems for the treatment of patients with chronic
neuromotor conditions. With offices in Boston (U.S.) and Paris (France),
we are collaborating with world-class research institutions to rapidly
bring to market disruptive products for treating spasticity, paralysis
and muscle weakness. More than 48 million patients in the US, Europe and
China suffer disabilities due to stroke, cerebral palsy, multiple
sclerosis, spinal cord injury, traumatic brain injury, Parkinson's
disease and other neurological disorders. At PathMaker, we are opening
up a new era of non-invasive neurotherapy for patients suffering from
chronic neuromotor conditions. For more information, please visit the
company website at

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at